JP2012051888A5 - - Google Patents

Download PDF

Info

Publication number
JP2012051888A5
JP2012051888A5 JP2011191990A JP2011191990A JP2012051888A5 JP 2012051888 A5 JP2012051888 A5 JP 2012051888A5 JP 2011191990 A JP2011191990 A JP 2011191990A JP 2011191990 A JP2011191990 A JP 2011191990A JP 2012051888 A5 JP2012051888 A5 JP 2012051888A5
Authority
JP
Japan
Prior art keywords
formula
lateral sclerosis
amyotrophic lateral
agent according
gene mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011191990A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012051888A (ja
JP5835729B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012051888A publication Critical patent/JP2012051888A/ja
Publication of JP2012051888A5 publication Critical patent/JP2012051888A5/ja
Application granted granted Critical
Publication of JP5835729B2 publication Critical patent/JP5835729B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011191990A 2010-09-02 2011-09-02 筋萎縮性側索硬化症の予防および治療用医薬組成物 Expired - Fee Related JP5835729B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37955810P 2010-09-02 2010-09-02
US61/379,558 2010-09-02

Publications (3)

Publication Number Publication Date
JP2012051888A JP2012051888A (ja) 2012-03-15
JP2012051888A5 true JP2012051888A5 (https=) 2014-10-16
JP5835729B2 JP5835729B2 (ja) 2015-12-24

Family

ID=45773059

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011191990A Expired - Fee Related JP5835729B2 (ja) 2010-09-02 2011-09-02 筋萎縮性側索硬化症の予防および治療用医薬組成物

Country Status (4)

Country Link
US (1) US9856210B2 (https=)
EP (1) EP2611437B1 (https=)
JP (1) JP5835729B2 (https=)
WO (1) WO2012029994A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10519421B2 (en) 2013-03-21 2019-12-31 Kyoto University Induction of motor neurons from pluripotent stem cells
CN104045598B (zh) * 2014-05-29 2017-02-15 烟台大学 一种含芳胺结构的硫脲类化合物及其制备方法和应用
CA3193811A1 (en) 2014-11-14 2016-05-19 Voyager Therapeutics, Inc. Compositions and methods of treating amyotrophic lateral sclerosis (als)
EP3246046A4 (en) * 2015-01-13 2018-12-05 Kyoto University Agent for preventing and/or treating amyotrophic lateral sclerosis
EP3618839A4 (en) 2017-05-05 2021-06-09 Voyager Therapeutics, Inc. COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
TW202413649A (zh) 2017-10-16 2024-04-01 美商航海家醫療公司 肌萎縮性脊髓側索硬化症(als)之治療
WO2021075476A1 (ja) 2019-10-18 2021-04-22 武田薬品工業株式会社 複素環化合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688138B1 (fr) 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US20030236287A1 (en) * 2002-05-03 2003-12-25 Piotrowski David W. Positive allosteric modulators of the nicotinic acetylcholine receptor
US8227643B2 (en) 2002-05-31 2012-07-24 Proteotech, Inc. Sirtuin 1 and the treatment of neurodegenerative diseases
WO2005092843A1 (en) 2004-03-29 2005-10-06 Neurosearch A/S Novel urea derivatives and their medical use
CN103251953A (zh) 2004-07-19 2013-08-21 约翰·霍普金斯大学 供免疫抑制的flt3抑制剂
US8329408B2 (en) * 2005-10-31 2012-12-11 Bayer Healthcare Llc Methods for prognosis and monitoring cancer therapy
BRPI0619794B8 (pt) 2005-12-13 2022-06-14 Univ Kyoto Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
GB0606429D0 (en) * 2006-03-30 2006-05-10 Novartis Ag Organic compounds
CA2645633A1 (en) * 2006-04-05 2007-11-01 Novartis Ag Combinations of therapeutic agents for treating cancer
GB0609378D0 (en) * 2006-05-11 2006-06-21 Novartis Ag Organic compounds
WO2008031835A2 (en) 2006-09-13 2008-03-20 Novartis Ag Method of treating autoimmune diseases using vegf-pathway inhibitors
EP2136809A4 (en) * 2007-03-20 2012-01-04 Curis Inc INHIBITORS OF RAF KINASE CONTAINING A ZINC BINDING FRAGMENT
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
US20090004213A1 (en) * 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
TW200848063A (en) * 2007-04-23 2008-12-16 Combinatorx Inc Methods and compositions for the treatment of neurodegenerative disorders
US8093425B2 (en) * 2007-04-30 2012-01-10 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
CA2694983A1 (en) * 2007-07-17 2009-01-22 Combinatorx, Incorporated Treatments of b-cell proliferative disorders
CA2734305A1 (en) 2008-08-15 2010-02-18 Board Of Regents, The University Of Texas System 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions

Similar Documents

Publication Publication Date Title
JP2012051888A5 (https=)
JP2014515013A5 (https=)
JP2014500861A5 (https=)
JP2013032389A5 (https=)
WO2012122340A8 (en) Soluble guanylate cyclase activators
CN110248926A (zh) Lsd1抑制剂及其制备方法和应用
JP2013542261A5 (https=)
JP2013534248A5 (https=)
JP2014508811A5 (https=)
JP2012502885A5 (https=)
EA201490320A1 (ru) Соединения тетрагидропиридопиридина и тетрагидропиридопиримидина и их применение в качестве модуляторов рецептора c5a
EP4643945A3 (en) Neuroactive steroids and methods of use thereof
JP2013537203A5 (https=)
PH12013500301A1 (en) Oxadiazole inhibitors of leukotriene production
JP2013512277A5 (https=)
JP2014521744A5 (https=)
JP2015523546A5 (https=)
JP2016540749A5 (https=)
JP2011088926A5 (https=)
MX2013008056A (es) 1,4-oxazepinas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2).
JP2014516033A5 (https=)
IN2014DN09347A (https=)
JP2015516419A5 (https=)
WO2012112447A3 (en) Histone deacetylase inhibitors and methods of use thereof
JP2013513607A5 (https=)